384 related articles for article (PubMed ID: 28377316)
1. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing.
Li Q; Wen H; Jia D; Guan X; Pan H; Yang Y; Yu S; Zhu Z; Xiang R; Pan W
Int J Pharm; 2017 Jun; 525(1):5-11. PubMed ID: 28377316
[TBL] [Abstract][Full Text] [Related]
2. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing.
Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW
Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468
[TBL] [Abstract][Full Text] [Related]
4. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing.
Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA
Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
Zhang P; Xu P; Chung S; Bandari S; Repka MA
Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
[TBL] [Abstract][Full Text] [Related]
6. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
[TBL] [Abstract][Full Text] [Related]
7. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
8. Effect of geometry on drug release from 3D printed tablets.
Goyanes A; Robles Martinez P; Buanz A; Basit AW; Gaisford S
Int J Pharm; 2015 Oct; 494(2):657-663. PubMed ID: 25934428
[TBL] [Abstract][Full Text] [Related]
9. 3D printing of tablets containing multiple drugs with defined release profiles.
Khaled SA; Burley JC; Alexander MR; Yang J; Roberts CJ
Int J Pharm; 2015 Oct; 494(2):643-650. PubMed ID: 26235921
[TBL] [Abstract][Full Text] [Related]
10. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems.
Fu J; Yin H; Yu X; Xie C; Jiang H; Jin Y; Sheng F
Int J Pharm; 2018 Oct; 549(1-2):370-379. PubMed ID: 30107218
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
12. Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone.
Chai X; Chai H; Wang X; Yang J; Li J; Zhao Y; Cai W; Tao T; Xiang X
Sci Rep; 2017 Jun; 7(1):2829. PubMed ID: 28588251
[TBL] [Abstract][Full Text] [Related]
13. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
[TBL] [Abstract][Full Text] [Related]
14. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing.
Skowyra J; Pietrzak K; Alhnan MA
Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
17. Abuse Deterrent Immediate Release Egg-Shaped Tablet (Egglets) Using 3D Printing Technology: Quality by Design to Optimize Drug Release and Extraction.
Nukala PK; Palekar S; Patki M; Patel K
AAPS PharmSciTech; 2019 Jan; 20(2):80. PubMed ID: 30645704
[TBL] [Abstract][Full Text] [Related]
18. Design and characterization of a novel 3D printed pressure-controlled drug delivery system.
Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W
Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171
[TBL] [Abstract][Full Text] [Related]
19. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
20. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers.
Zhao X; Wei W; Niu R; Li Q; Hu C; Jiang S
J Pharm Sci; 2022 Jan; 111(1):116-123. PubMed ID: 34303671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
